Identification of genetic determinants of micronucleus formation

The genetic determinants of micronuclei formation (MN).

Patient with rare neurodegenerative disorder improves with non-profit’s ASO therapy – Pharmaceutical Technology

Researchers at the non-profit n-Lorem discovered and developed a personalised ASO therapy to treat a rare neurological disease. Credit: SurfsUp via Shutterstock. A patient with

August 12, 2024

Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit

Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate

October 11, 2023

Italians show mixed adherence to Mediterranean diet, study reveals

A comprehensive study on the Mediterranean Diet adherence among Italians reveals a predominant medium adherence level, with significant influences from demographic and lifestyle factors, despite

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.